A detailed history of M&G PLC transactions in Vaccitech PLC stock. As of the latest transaction made, M&G PLC holds 5,197,349 shares of VACC stock, worth $17.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,197,349
Previous 5,197,349 -0.0%
Holding current value
$17.7 Million
Previous $5.2 Billion -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$3.41 - $3.7 $17.7 Million - $19.2 Million
5,197,349 New
5,197,349 $10.4 Billion

Others Institutions Holding VACC

About Vaccitech plc


  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track This Portfolio

Track M&G PLC Portfolio

Follow M&G PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G PLC, based on Form 13F filings with the SEC.

News

Stay updated on M&G PLC with notifications on news.